POLBF (Poolbeg Pharma) Price-to-Tangible-Book : 4.37 (As of May. 12, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Poolbeg Pharma Price-to-Tangible-Book?

As of today (2025-05-12), Poolbeg Pharma's share price is $0.118. Poolbeg Pharma's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was $0.03. Hence, Poolbeg Pharma's Price to Tangible Book Ratio of today is 4.37.

The historical rank and industry rank for Poolbeg Pharma's Price-to-Tangible-Book or its related term are showing as below:

POLBF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.33 Med: 2.56 Max: 6.19
Current: 1.48

During the past 3 years, Poolbeg Pharma's highest Price to Tangible Book Ratio was 6.19. The lowest was 1.33. And the median was 2.56.

POLBF's Price-to-Tangible-Book is ranked better than
73.24% of 1207 companies
in the Biotechnology industry
Industry Median: 2.61 vs POLBF: 1.48

A closely related ratio is called PB Ratio. As of today, Poolbeg Pharma's share price is $0.118. Poolbeg Pharma's Book Value per Sharefor the quarter that ended in Jun. 2024 was $0.03. Hence, Poolbeg Pharma's P/B Ratio of today is 3.69.

Poolbeg Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Poolbeg Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Price-to-Tangible-Book Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Tangible-Book

1.87

3.59

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Price-to-Tangible-Book	Get a 7-Day Free Trial			1.65	1.87	3.19	3.59	6.48

Competitive Comparison of Poolbeg Pharma's Price-to-Tangible-Book

For the Biotechnology subindustry, Poolbeg Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poolbeg Pharma's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Poolbeg Pharma Price-to-Tangible-Book Calculation

Poolbeg Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2024 )
	=	0.118	/	0.027
	=	4.37

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Poolbeg Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

POLB:UK 7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.